A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis

A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is an innovative laparoscopic intraperitoneal chemotherapy approach with the advantage of a deeper tissue penetration. Thus far, oxaliplatin has been administered at an arbitrary dose of 92 mg/m<sup>2</sup>, cisplatin at 7.5 mg/m&l...

Full description

Bibliographic Details
Main Authors: Manuela Robella, Michele De Simone, Paola Berchialla, Monica Argenziano, Alice Borsano, Shoeb Ansari, Ornella Abollino, Eleonora Ficiarà, Armando Cinquegrana, Roberta Cavalli, Marco Vaira
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
PIPAC
peritoneal carcinomatosis
chemotherapy
phase I
locoregional
Online Access:https://www.mdpi.com/2072-6694/13/5/1060

Internet

https://www.mdpi.com/2072-6694/13/5/1060

Similar Items